Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 3, No. 2, 2011
Issue release date: February 2011
Section title: Research Article
Free Access
J Innate Immun 2011;3:180–199

Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis

Lionakis M.S.a · Lim J.K.a · Lee C.-C.R.b · Murphy P.M.a
aMolecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, and bLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA
email Corresponding Author

Dr. Philip M. Murphy

Molecular Signaling Section, Laboratory of Molecular Immunology

National Institutes of Health, Building 10, Room 11N113, 9000 Rockville Pike

Bethesda, MD 20892 (USA)

Tel. +1 301 496 8616, Fax +1 301 402 4369, E-Mail pmm@nih.gov


  1. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:1232–1239.
  2. Papadimitriou JM, Ashman RB: The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol 1986;150:257–265.
  3. Spellberg B, Ibrahim AS, Edwards JE Jr, Filler SG: Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 2005;192:336–343.
  4. MacCallum DM, Odds FC: Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection. Antimicrob Agents Chemother 2004;48:4911–4914.
  5. Fulurija A, Ashman RB, Papadimitriou JM: Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 1996;142:3487–3496.
  6. Romani L, Mencacci A, Cenci E, Del Sero G, Bistoni F, Puccetti P: An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J Immunol 1997;158:2356–2362.
  7. Qian Q, Jutila MA, Van Rooijen N, Cutler JE: Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 1994;152:5000–5008.
  8. Vázquez-Torres A, Balish E: Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev 1997;61:170–192.
  9. Mahanty S, Greenfield RA, Joyce WA, Kincade PW: Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 1988;56:3162–3166.
  10. Schuit KE: Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun 1979;24:932–938.
  11. Tsou CL, Peters W, Si Y, Slaymaker S, Slaymaker S, Aslanian AM, et al: Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007;117:902–909.
  12. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, et al: RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009;10:83–91.
  13. Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y: Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-γ-dependent pathway. J Biol Chem 2002;277:20026–20032.
  14. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 2005;202:1087–1098.
  15. Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000;105:985–993.
  16. Sarin SK, Sabba C, Groszmann RJ: Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. Am J Physiol 1990;258:G365–G369.
  17. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR: Nonfilamentous C. albicans mutants are avirulent. Cell 1997;90:939–949.
  18. Sudbery P, Gow N, Berman J: The distinct morphogenic states of Candida albicans. Trends Microbiol 2004;12:317–324.
  19. Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bartoli A, Bistoni F: Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans. J Neuroimmunol 1991;32:249–257.
  20. Lawson LJ, Perry VH, Gordon S: Turnover of resident microglia in the normal adult mouse brain. Neuroscience 1992;48:405–415.
  21. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25–31.
  22. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL: Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun 2008;76:97–102.
  23. Cutler JE, Poor AH: Effect of mouse phagocytes on Candida albicans in in vivo chambers. Infect Immun 1981;31:1110–1116.
  24. Diamond RD, Krzesicki R, Jao W: Damage to hyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest 1978;61:349–359.
  25. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989;320:365–376.
  26. Gargan RA, Hamilton-Miller JM, Brumfitt W: Effect of pH and osmolality on in vitro phagocytosis and killing by neutrophils in urine. Infect Immun 1993:61:8–12.
  27. Naglik J, Albrecht A, Bader O, Hube B: Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 2004;6:915–926.
  28. Krause PJ, Malech HL, Kristie J, Kosciol CM, Herson VC, Eisenfeld L, et al: Polymorphonuclear leukocyte heterogeneity in neonates and adults. Blood 1986;68:200–204.
  29. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F: Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004;21:215–226.
  30. Mencacci A, Montagnoli C, Bacci A, Cenci E, Pitzurra L, Spreca A, et al: CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 2002;169:3180–3190.
  31. Romani L, Mencacci A, Cenci E, Spaccapelo R, Del Sero G, Nicoletti I, et al: Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol 1997;158:5349–5356.
  32. Redmond HP, Shou J, Gallagher HJ, Kelly CJ, Daly JM: Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J Immunol 1993;150:3427–3433.
  33. Serbina NV, Jia T, Hohl TM, Pamer EG: Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008;26:421–452.
  34. Getts DR, Terry RL, Getts MT, Müller M, Rana S, Shrestha B, et al: Ly6c+ ‘inflammatory monocytes’ are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 2008;205:2319–2337.
  35. Romani L, Mencacci A, Cenci E, Spaccapelo R, Schiaffella E, Tonnetti L, et al: Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect Immun 1993;61:3769–3774.
  36. Algarra I, Ortega E, Serrano MJ, Alvarez de Cienfuegos G, Gaforio JJ: Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol Med Microbiol 2002;33:159–163.
  37. d’Ostiani CF, Del Sero G, Bacci A, Montagnoli C, Spreca A, Mencacci A, et al: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000;191:1661–1674.